Euro heart failure survey: Medical treatment not in line with current guidelines

Zeitschrift fur Kardiologie

Volumn 94, Issue 8, 2005, Pages 510-515

  Drechsler, K ^b   Dietz, R ^c   Klein, H ^d   Wollert, K C ^e   Storp, D ^f   Molling, J ^g   Zeymer, U ^h   Niebauer, J ^a  

^a Institut für Sportmedizin des Landes Salzburg   (Austria)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Augenklinik   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Agnes Karll Krankenhaus   (Germany)

^g Pfeiffersche Stiftungen   (Germany)

^h KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Diagnosis; Guidelines; Heart failure; Medication; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLYCOSIDE; LOOP DIURETIC AGENT; NITRATE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; WARFARIN;

ADULT; AGED; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DIURETIC THERAPY; DRUG DOSE REGIMEN; DRUG INDICATION; ECHOCARDIOGRAPHY; FEMALE; GERMANY; HEALTH CENTER; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; SCREENING; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; DIURETICS; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HEALTH SURVEYS; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; PRACTICE GUIDELINES; SEX FACTORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; STATISTICS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 23744437097     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0245-y     Document Type: Review

References (12)

1. Cibis.II Investigators and Committees (1999) The cardiac insufficiency bisoprolol study II: a randomized trial. Lancet 353:9-13
2. Cleland JG, Clark A, Caplin JL (2000) Taking heart failure seriously. BMJ 321(7269):1095-1096
3. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003) The Euro-Heart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:464-474
4. Cohen-Solal A (2000) A national survey of heart failure in French hospitals. Eur Heart J 21:763-769
5. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26:215-225
6. Fliser D (2003) Symptomatische Hyperkaliämie: Deutsches Ärzteblatt 100:1657-1659
7. Hoppe UC, Erdmann E (2001) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 90:218-237
8. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 351:543-551
9. MERIT-HF study group (1999) Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001-2007
10. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20(6):447-455
11. Ormiston TM, Salpeter SR (2003) Beta-blocker use in patients with heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice. Heart Fail Monk 4(2):45-54
12. The Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology (1999) Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative. Eur J Heart Fail 2:139-144